nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketoprofen—SLCO1A2—Chlorambucil—testicular cancer	0.194	0.256	CbGbCtD
Ketoprofen—PTGS1—Ifosfamide—testicular cancer	0.0762	0.1	CbGbCtD
Ketoprofen—SLC22A11—Methotrexate—testicular cancer	0.0521	0.0686	CbGbCtD
Ketoprofen—SLC22A7—Methotrexate—testicular cancer	0.0496	0.0654	CbGbCtD
Ketoprofen—ABCC4—Methotrexate—testicular cancer	0.0485	0.0639	CbGbCtD
Ketoprofen—CYP2C8—Ifosfamide—testicular cancer	0.044	0.058	CbGbCtD
Ketoprofen—PTGS2—Cisplatin—testicular cancer	0.0439	0.0579	CbGbCtD
Ketoprofen—PTGS2—Etoposide—testicular cancer	0.0431	0.0568	CbGbCtD
Ketoprofen—PTGS1—Etoposide—testicular cancer	0.0364	0.048	CbGbCtD
Ketoprofen—SLCO1A2—Methotrexate—testicular cancer	0.0348	0.0458	CbGbCtD
Ketoprofen—CYP2C9—Ifosfamide—testicular cancer	0.0307	0.0404	CbGbCtD
Ketoprofen—SLC22A8—Methotrexate—testicular cancer	0.0303	0.0399	CbGbCtD
Ketoprofen—SLC22A6—Methotrexate—testicular cancer	0.0211	0.0278	CbGbCtD
Ketoprofen—CYP2C8—Etoposide—testicular cancer	0.021	0.0277	CbGbCtD
Ketoprofen—ALB—Methotrexate—testicular cancer	0.018	0.0237	CbGbCtD
Ketoprofen—CYP2C9—Cisplatin—testicular cancer	0.0149	0.0197	CbGbCtD
Ketoprofen—CXCR1—Peptide ligand-binding receptors—INSL3—testicular cancer	0.00204	0.0483	CbGpPWpGaD
Ketoprofen—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.00204	0.0483	CbGpPWpGaD
Ketoprofen—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.00185	0.0438	CbGpPWpGaD
Ketoprofen—CXCR1—Differentiation Pathway—KITLG—testicular cancer	0.00181	0.0428	CbGpPWpGaD
Ketoprofen—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGDS—testicular cancer	0.00179	0.0424	CbGpPWpGaD
Ketoprofen—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.00156	0.0368	CbGpPWpGaD
Ketoprofen—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGDS—testicular cancer	0.00142	0.0337	CbGpPWpGaD
Ketoprofen—CXCR1—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	0.00137	0.0324	CbGpPWpGaD
Ketoprofen—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.0013	0.0307	CbGpPWpGaD
Ketoprofen—CXCR1—Differentiation Pathway—KIT—testicular cancer	0.00123	0.0292	CbGpPWpGaD
Ketoprofen—ABCC4—Ectoderm Differentiation—TFAP2C—testicular cancer	0.00123	0.0291	CbGpPWpGaD
Ketoprofen—CXCL8—Syndecan-3-mediated signaling events—FGFR3—testicular cancer	0.00117	0.0278	CbGpPWpGaD
Ketoprofen—ABCC4—NRF2 pathway—SLC2A6—testicular cancer	0.00108	0.0254	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR ligand binding—INSL3—testicular cancer	0.00104	0.0247	CbGpPWpGaD
Ketoprofen—SLC22A11—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000927	0.0219	CbGpPWpGaD
Ketoprofen—CXCL8—Peptide ligand-binding receptors—INSL3—testicular cancer	0.000921	0.0218	CbGpPWpGaD
Ketoprofen—CXCL8—Bladder Cancer—FGFR3—testicular cancer	0.00086	0.0203	CbGpPWpGaD
Ketoprofen—SLC22A7—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000841	0.0199	CbGpPWpGaD
Ketoprofen—CXCL8—Syndecan-2-mediated signaling events—FGFR3—testicular cancer	0.000763	0.0181	CbGpPWpGaD
Ketoprofen—SLC22A8—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000707	0.0167	CbGpPWpGaD
Ketoprofen—PTGS1—Arachidonic acid metabolism—HPGDS—testicular cancer	0.000648	0.0153	CbGpPWpGaD
Ketoprofen—SLCO1A2—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000628	0.0148	CbGpPWpGaD
Ketoprofen—CXCL8—Syndecan-2-mediated signaling events—MMP2—testicular cancer	0.000621	0.0147	CbGpPWpGaD
Ketoprofen—CXCL8—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	0.000618	0.0146	CbGpPWpGaD
Ketoprofen—CXCL8—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP2—testicular cancer	0.000607	0.0144	CbGpPWpGaD
Ketoprofen—SLC22A6—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.00059	0.014	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR downstream signaling—INSL3—testicular cancer	0.000589	0.0139	CbGpPWpGaD
Ketoprofen—PTGS2—Aryl Hydrocarbon Receptor—HPGDS—testicular cancer	0.00055	0.013	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—INSL3—testicular cancer	0.000535	0.0127	CbGpPWpGaD
Ketoprofen—PTGS2—Arachidonic acid metabolism—HPGDS—testicular cancer	0.000514	0.0122	CbGpPWpGaD
Ketoprofen—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—H2AFZ—testicular cancer	0.000474	0.0112	CbGpPWpGaD
Ketoprofen—SLC22A11—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000471	0.0111	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR ligand binding—INSL3—testicular cancer	0.000471	0.0111	CbGpPWpGaD
Ketoprofen—SLC22A7—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000427	0.0101	CbGpPWpGaD
Ketoprofen—CYP2C8—Arachidonic acid metabolism—HPGDS—testicular cancer	0.000419	0.0099	CbGpPWpGaD
Ketoprofen—CXCL8—ATF-2 transcription factor network—MMP2—testicular cancer	0.000418	0.00989	CbGpPWpGaD
Ketoprofen—CXCL8—LPA receptor mediated events—MMP2—testicular cancer	0.000392	0.00927	CbGpPWpGaD
Ketoprofen—SLC22A8—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000359	0.0085	CbGpPWpGaD
Ketoprofen—PTGS2—C-MYB transcription factor network—MAD1L1—testicular cancer	0.000356	0.00842	CbGpPWpGaD
Ketoprofen—ABCC4—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000344	0.00815	CbGpPWpGaD
Ketoprofen—CYP2C9—Arachidonic acid metabolism—HPGDS—testicular cancer	0.000341	0.00806	CbGpPWpGaD
Ketoprofen—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—testicular cancer	0.000328	0.00775	CbGpPWpGaD
Ketoprofen—SLCO1A2—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000319	0.00755	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—INSL3—testicular cancer	0.000316	0.00748	CbGpPWpGaD
Ketoprofen—ALB—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000307	0.00725	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular Senescence—H2AFZ—testicular cancer	0.0003	0.0071	CbGpPWpGaD
Ketoprofen—SLC22A6—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.0003	0.00709	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—INSL3—testicular cancer	0.000266	0.00629	CbGpPWpGaD
Ketoprofen—PTGS2—C-MYB transcription factor network—H2AFZ—testicular cancer	0.000248	0.00587	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—INSL3—testicular cancer	0.000242	0.00571	CbGpPWpGaD
Ketoprofen—PTGS1—Biological oxidations—HPGDS—testicular cancer	0.000241	0.00571	CbGpPWpGaD
Ketoprofen—PTGS2—C-MYB transcription factor network—KITLG—testicular cancer	0.000228	0.0054	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular responses to stress—H2AFZ—testicular cancer	0.000227	0.00536	CbGpPWpGaD
Ketoprofen—Toxic epidermal necrolysis—Doxorubicin—testicular cancer	0.000215	0.00108	CcSEcCtD
Ketoprofen—Decreased appetite—Cisplatin—testicular cancer	0.000215	0.00108	CcSEcCtD
Ketoprofen—Diarrhoea—Dactinomycin—testicular cancer	0.000214	0.00108	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000213	0.00107	CcSEcCtD
Ketoprofen—Vomiting—Bleomycin—testicular cancer	0.000213	0.00107	CcSEcCtD
Ketoprofen—Drowsiness—Methotrexate—testicular cancer	0.000213	0.00107	CcSEcCtD
Ketoprofen—Rash—Bleomycin—testicular cancer	0.000211	0.00106	CcSEcCtD
Ketoprofen—Gastritis—Doxorubicin—testicular cancer	0.000211	0.00106	CcSEcCtD
Ketoprofen—Dermatitis—Bleomycin—testicular cancer	0.000211	0.00106	CcSEcCtD
Ketoprofen—Hypersensitivity—Ifosfamide—testicular cancer	0.000211	0.00106	CcSEcCtD
Ketoprofen—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.000211	0.00106	CcSEcCtD
Ketoprofen—Renal failure—Methotrexate—testicular cancer	0.000209	0.00105	CcSEcCtD
Ketoprofen—Stomatitis—Methotrexate—testicular cancer	0.000207	0.00104	CcSEcCtD
Ketoprofen—Conjunctivitis—Methotrexate—testicular cancer	0.000207	0.00104	CcSEcCtD
Ketoprofen—Asthma—Doxorubicin—testicular cancer	0.000206	0.00104	CcSEcCtD
Ketoprofen—Asthenia—Ifosfamide—testicular cancer	0.000206	0.00103	CcSEcCtD
Ketoprofen—Sweating—Methotrexate—testicular cancer	0.000204	0.00102	CcSEcCtD
Ketoprofen—Photosensitivity reaction—Epirubicin—testicular cancer	0.000204	0.00102	CcSEcCtD
Ketoprofen—Feeling abnormal—Cisplatin—testicular cancer	0.000204	0.00102	CcSEcCtD
Ketoprofen—Paraesthesia—Etoposide—testicular cancer	0.000203	0.00102	CcSEcCtD
Ketoprofen—Weight increased—Epirubicin—testicular cancer	0.000203	0.00102	CcSEcCtD
Ketoprofen—Pruritus—Ifosfamide—testicular cancer	0.000203	0.00102	CcSEcCtD
Ketoprofen—Haematuria—Methotrexate—testicular cancer	0.000203	0.00102	CcSEcCtD
Ketoprofen—Pancreatitis—Doxorubicin—testicular cancer	0.000202	0.00102	CcSEcCtD
Ketoprofen—Weight decreased—Epirubicin—testicular cancer	0.000202	0.00101	CcSEcCtD
Ketoprofen—Dyspnoea—Etoposide—testicular cancer	0.000202	0.00101	CcSEcCtD
Ketoprofen—Somnolence—Etoposide—testicular cancer	0.000201	0.00101	CcSEcCtD
Ketoprofen—Epistaxis—Methotrexate—testicular cancer	0.0002	0.00101	CcSEcCtD
Ketoprofen—Nausea—Bleomycin—testicular cancer	0.000199	0.001	CcSEcCtD
Ketoprofen—Drowsiness—Epirubicin—testicular cancer	0.000199	0.001	CcSEcCtD
Ketoprofen—Vomiting—Dactinomycin—testicular cancer	0.000199	0.001	CcSEcCtD
Ketoprofen—Agranulocytosis—Methotrexate—testicular cancer	0.000198	0.000997	CcSEcCtD
Ketoprofen—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.000197	0.000991	CcSEcCtD
Ketoprofen—Rash—Dactinomycin—testicular cancer	0.000197	0.000991	CcSEcCtD
Ketoprofen—Decreased appetite—Etoposide—testicular cancer	0.000197	0.000989	CcSEcCtD
Ketoprofen—Diarrhoea—Ifosfamide—testicular cancer	0.000196	0.000986	CcSEcCtD
Ketoprofen—Renal failure—Epirubicin—testicular cancer	0.000196	0.000983	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Etoposide—testicular cancer	0.000195	0.000982	CcSEcCtD
Ketoprofen—Fatigue—Etoposide—testicular cancer	0.000195	0.000981	CcSEcCtD
Ketoprofen—Jaundice—Epirubicin—testicular cancer	0.000194	0.000975	CcSEcCtD
Ketoprofen—Stomatitis—Epirubicin—testicular cancer	0.000194	0.000975	CcSEcCtD
Ketoprofen—Constipation—Etoposide—testicular cancer	0.000194	0.000973	CcSEcCtD
Ketoprofen—Conjunctivitis—Epirubicin—testicular cancer	0.000193	0.000972	CcSEcCtD
Ketoprofen—Hepatitis—Methotrexate—testicular cancer	0.000191	0.000959	CcSEcCtD
Ketoprofen—Sweating—Epirubicin—testicular cancer	0.000191	0.000959	CcSEcCtD
Ketoprofen—Haematuria—Epirubicin—testicular cancer	0.00019	0.000953	CcSEcCtD
Ketoprofen—Dizziness—Ifosfamide—testicular cancer	0.000189	0.000953	CcSEcCtD
Ketoprofen—Pharyngitis—Methotrexate—testicular cancer	0.000189	0.000952	CcSEcCtD
Ketoprofen—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000188	0.000947	CcSEcCtD
Ketoprofen—Weight increased—Doxorubicin—testicular cancer	0.000188	0.000944	CcSEcCtD
Ketoprofen—Epistaxis—Epirubicin—testicular cancer	0.000188	0.000943	CcSEcCtD
Ketoprofen—Weight decreased—Doxorubicin—testicular cancer	0.000187	0.000939	CcSEcCtD
Ketoprofen—Feeling abnormal—Etoposide—testicular cancer	0.000187	0.000938	CcSEcCtD
Ketoprofen—Nausea—Dactinomycin—testicular cancer	0.000186	0.000934	CcSEcCtD
Ketoprofen—Agranulocytosis—Epirubicin—testicular cancer	0.000186	0.000933	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Etoposide—testicular cancer	0.000185	0.00093	CcSEcCtD
Ketoprofen—Drowsiness—Doxorubicin—testicular cancer	0.000184	0.000925	CcSEcCtD
Ketoprofen—Visual impairment—Methotrexate—testicular cancer	0.000184	0.000924	CcSEcCtD
Ketoprofen—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000182	0.000917	CcSEcCtD
Ketoprofen—Vomiting—Ifosfamide—testicular cancer	0.000182	0.000916	CcSEcCtD
Ketoprofen—Hypersensitivity—Cisplatin—testicular cancer	0.000182	0.000915	CcSEcCtD
Ketoprofen—Renal failure—Doxorubicin—testicular cancer	0.000181	0.00091	CcSEcCtD
Ketoprofen—Rash—Ifosfamide—testicular cancer	0.000181	0.000908	CcSEcCtD
Ketoprofen—Dermatitis—Ifosfamide—testicular cancer	0.000181	0.000907	CcSEcCtD
Ketoprofen—Erythema multiforme—Methotrexate—testicular cancer	0.00018	0.000907	CcSEcCtD
Ketoprofen—Urticaria—Etoposide—testicular cancer	0.00018	0.000904	CcSEcCtD
Ketoprofen—Stomatitis—Doxorubicin—testicular cancer	0.000179	0.000902	CcSEcCtD
Ketoprofen—Jaundice—Doxorubicin—testicular cancer	0.000179	0.000902	CcSEcCtD
Ketoprofen—Rhinitis—Epirubicin—testicular cancer	0.000179	0.0009	CcSEcCtD
Ketoprofen—Abdominal pain—Etoposide—testicular cancer	0.000179	0.000899	CcSEcCtD
Ketoprofen—Conjunctivitis—Doxorubicin—testicular cancer	0.000179	0.000899	CcSEcCtD
Ketoprofen—Hepatitis—Epirubicin—testicular cancer	0.000179	0.000898	CcSEcCtD
Ketoprofen—Tinnitus—Methotrexate—testicular cancer	0.000178	0.000894	CcSEcCtD
Ketoprofen—Asthenia—Cisplatin—testicular cancer	0.000177	0.000891	CcSEcCtD
Ketoprofen—Pharyngitis—Epirubicin—testicular cancer	0.000177	0.000891	CcSEcCtD
Ketoprofen—Sweating—Doxorubicin—testicular cancer	0.000176	0.000887	CcSEcCtD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—HPGDS—testicular cancer	0.000176	0.00417	CbGpPWpGaD
Ketoprofen—Haematuria—Doxorubicin—testicular cancer	0.000175	0.000882	CcSEcCtD
Ketoprofen—Epistaxis—Doxorubicin—testicular cancer	0.000174	0.000873	CcSEcCtD
Ketoprofen—Visual impairment—Epirubicin—testicular cancer	0.000172	0.000865	CcSEcCtD
Ketoprofen—Agranulocytosis—Doxorubicin—testicular cancer	0.000172	0.000863	CcSEcCtD
Ketoprofen—Chills—Methotrexate—testicular cancer	0.000171	0.000861	CcSEcCtD
Ketoprofen—Nausea—Ifosfamide—testicular cancer	0.00017	0.000856	CcSEcCtD
Ketoprofen—Diarrhoea—Cisplatin—testicular cancer	0.000169	0.00085	CcSEcCtD
Ketoprofen—Erythema multiforme—Epirubicin—testicular cancer	0.000169	0.000849	CcSEcCtD
Ketoprofen—Alopecia—Methotrexate—testicular cancer	0.000169	0.000848	CcSEcCtD
Ketoprofen—Hypersensitivity—Etoposide—testicular cancer	0.000167	0.000838	CcSEcCtD
Ketoprofen—Tinnitus—Epirubicin—testicular cancer	0.000166	0.000837	CcSEcCtD
Ketoprofen—Erythema—Methotrexate—testicular cancer	0.000166	0.000835	CcSEcCtD
Ketoprofen—Flushing—Epirubicin—testicular cancer	0.000166	0.000833	CcSEcCtD
Ketoprofen—Rhinitis—Doxorubicin—testicular cancer	0.000166	0.000833	CcSEcCtD
Ketoprofen—Hepatitis—Doxorubicin—testicular cancer	0.000165	0.000831	CcSEcCtD
Ketoprofen—Pharyngitis—Doxorubicin—testicular cancer	0.000164	0.000824	CcSEcCtD
Ketoprofen—Dysgeusia—Methotrexate—testicular cancer	0.000163	0.000818	CcSEcCtD
Ketoprofen—Asthenia—Etoposide—testicular cancer	0.000162	0.000816	CcSEcCtD
Ketoprofen—Chills—Epirubicin—testicular cancer	0.00016	0.000805	CcSEcCtD
Ketoprofen—Pruritus—Etoposide—testicular cancer	0.00016	0.000805	CcSEcCtD
Ketoprofen—Arrhythmia—Epirubicin—testicular cancer	0.00016	0.000802	CcSEcCtD
Ketoprofen—Visual impairment—Doxorubicin—testicular cancer	0.000159	0.0008	CcSEcCtD
Ketoprofen—Alopecia—Epirubicin—testicular cancer	0.000158	0.000793	CcSEcCtD
Ketoprofen—Vomiting—Cisplatin—testicular cancer	0.000157	0.00079	CcSEcCtD
Ketoprofen—Erythema multiforme—Doxorubicin—testicular cancer	0.000156	0.000785	CcSEcCtD
Ketoprofen—PTGS2—C-MYB transcription factor network—KIT—testicular cancer	0.000156	0.00369	CbGpPWpGaD
Ketoprofen—ALB—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000156	0.00369	CbGpPWpGaD
Ketoprofen—Rash—Cisplatin—testicular cancer	0.000156	0.000783	CcSEcCtD
Ketoprofen—CYP2C8—Biological oxidations—HPGDS—testicular cancer	0.000156	0.00369	CbGpPWpGaD
Ketoprofen—Dermatitis—Cisplatin—testicular cancer	0.000156	0.000782	CcSEcCtD
Ketoprofen—Erythema—Epirubicin—testicular cancer	0.000155	0.000781	CcSEcCtD
Ketoprofen—Diarrhoea—Etoposide—testicular cancer	0.000155	0.000778	CcSEcCtD
Ketoprofen—Ill-defined disorder—Methotrexate—testicular cancer	0.000154	0.000775	CcSEcCtD
Ketoprofen—Tinnitus—Doxorubicin—testicular cancer	0.000154	0.000774	CcSEcCtD
Ketoprofen—Anaemia—Methotrexate—testicular cancer	0.000154	0.000772	CcSEcCtD
Ketoprofen—Flushing—Doxorubicin—testicular cancer	0.000153	0.000771	CcSEcCtD
Ketoprofen—Flatulence—Epirubicin—testicular cancer	0.000153	0.00077	CcSEcCtD
Ketoprofen—Tension—Epirubicin—testicular cancer	0.000153	0.000767	CcSEcCtD
Ketoprofen—Dysgeusia—Epirubicin—testicular cancer	0.000152	0.000765	CcSEcCtD
Ketoprofen—Nervousness—Epirubicin—testicular cancer	0.000151	0.000759	CcSEcCtD
Ketoprofen—Malaise—Methotrexate—testicular cancer	0.00015	0.000753	CcSEcCtD
Ketoprofen—Dizziness—Etoposide—testicular cancer	0.00015	0.000752	CcSEcCtD
Ketoprofen—Vertigo—Methotrexate—testicular cancer	0.000149	0.00075	CcSEcCtD
Ketoprofen—Chills—Doxorubicin—testicular cancer	0.000148	0.000745	CcSEcCtD
Ketoprofen—Arrhythmia—Doxorubicin—testicular cancer	0.000148	0.000742	CcSEcCtD
Ketoprofen—Nausea—Cisplatin—testicular cancer	0.000147	0.000738	CcSEcCtD
Ketoprofen—Alopecia—Doxorubicin—testicular cancer	0.000146	0.000734	CcSEcCtD
Ketoprofen—Ill-defined disorder—Epirubicin—testicular cancer	0.000144	0.000725	CcSEcCtD
Ketoprofen—Convulsion—Methotrexate—testicular cancer	0.000144	0.000723	CcSEcCtD
Ketoprofen—Vomiting—Etoposide—testicular cancer	0.000144	0.000723	CcSEcCtD
Ketoprofen—Erythema—Doxorubicin—testicular cancer	0.000144	0.000723	CcSEcCtD
Ketoprofen—Anaemia—Epirubicin—testicular cancer	0.000144	0.000722	CcSEcCtD
Ketoprofen—Rash—Etoposide—testicular cancer	0.000143	0.000717	CcSEcCtD
Ketoprofen—CXCL8—Signaling Pathways—INSL3—testicular cancer	0.000143	0.00338	CbGpPWpGaD
Ketoprofen—Dermatitis—Etoposide—testicular cancer	0.000143	0.000717	CcSEcCtD
Ketoprofen—Headache—Etoposide—testicular cancer	0.000142	0.000713	CcSEcCtD
Ketoprofen—Flatulence—Doxorubicin—testicular cancer	0.000142	0.000712	CcSEcCtD
Ketoprofen—Myalgia—Methotrexate—testicular cancer	0.000141	0.000711	CcSEcCtD
Ketoprofen—Tension—Doxorubicin—testicular cancer	0.000141	0.00071	CcSEcCtD
Ketoprofen—Dysgeusia—Doxorubicin—testicular cancer	0.000141	0.000708	CcSEcCtD
Ketoprofen—Malaise—Epirubicin—testicular cancer	0.00014	0.000705	CcSEcCtD
Ketoprofen—Discomfort—Methotrexate—testicular cancer	0.00014	0.000702	CcSEcCtD
Ketoprofen—Nervousness—Doxorubicin—testicular cancer	0.00014	0.000702	CcSEcCtD
Ketoprofen—Vertigo—Epirubicin—testicular cancer	0.00014	0.000702	CcSEcCtD
Ketoprofen—Palpitations—Epirubicin—testicular cancer	0.000137	0.000691	CcSEcCtD
Ketoprofen—Confusional state—Methotrexate—testicular cancer	0.000137	0.000687	CcSEcCtD
Ketoprofen—Anaphylactic shock—Methotrexate—testicular cancer	0.000136	0.000681	CcSEcCtD
Ketoprofen—Convulsion—Epirubicin—testicular cancer	0.000135	0.000677	CcSEcCtD
Ketoprofen—Infection—Methotrexate—testicular cancer	0.000135	0.000677	CcSEcCtD
Ketoprofen—Nausea—Etoposide—testicular cancer	0.000134	0.000676	CcSEcCtD
Ketoprofen—Hypertension—Epirubicin—testicular cancer	0.000134	0.000675	CcSEcCtD
Ketoprofen—Ill-defined disorder—Doxorubicin—testicular cancer	0.000133	0.000671	CcSEcCtD
Ketoprofen—Anaemia—Doxorubicin—testicular cancer	0.000133	0.000668	CcSEcCtD
Ketoprofen—Thrombocytopenia—Methotrexate—testicular cancer	0.000133	0.000667	CcSEcCtD
Ketoprofen—Myalgia—Epirubicin—testicular cancer	0.000132	0.000665	CcSEcCtD
Ketoprofen—Anxiety—Epirubicin—testicular cancer	0.000132	0.000663	CcSEcCtD
Ketoprofen—Hyperhidrosis—Methotrexate—testicular cancer	0.000131	0.000659	CcSEcCtD
Ketoprofen—Discomfort—Epirubicin—testicular cancer	0.000131	0.000657	CcSEcCtD
Ketoprofen—Malaise—Doxorubicin—testicular cancer	0.00013	0.000652	CcSEcCtD
Ketoprofen—Dry mouth—Epirubicin—testicular cancer	0.000129	0.000651	CcSEcCtD
Ketoprofen—Vertigo—Doxorubicin—testicular cancer	0.000129	0.00065	CcSEcCtD
Ketoprofen—Anorexia—Methotrexate—testicular cancer	0.000129	0.00065	CcSEcCtD
Ketoprofen—Confusional state—Epirubicin—testicular cancer	0.000128	0.000643	CcSEcCtD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	0.000128	0.00303	CbGpPWpGaD
Ketoprofen—Palpitations—Doxorubicin—testicular cancer	0.000127	0.000639	CcSEcCtD
Ketoprofen—Anaphylactic shock—Epirubicin—testicular cancer	0.000127	0.000638	CcSEcCtD
Ketoprofen—Oedema—Epirubicin—testicular cancer	0.000127	0.000638	CcSEcCtD
Ketoprofen—CYP2C9—Biological oxidations—HPGDS—testicular cancer	0.000127	0.003	CbGpPWpGaD
Ketoprofen—Infection—Epirubicin—testicular cancer	0.000126	0.000634	CcSEcCtD
Ketoprofen—Shock—Epirubicin—testicular cancer	0.000125	0.000627	CcSEcCtD
Ketoprofen—Convulsion—Doxorubicin—testicular cancer	0.000125	0.000626	CcSEcCtD
Ketoprofen—Thrombocytopenia—Epirubicin—testicular cancer	0.000124	0.000624	CcSEcCtD
Ketoprofen—Hypertension—Doxorubicin—testicular cancer	0.000124	0.000624	CcSEcCtD
Ketoprofen—Tachycardia—Epirubicin—testicular cancer	0.000124	0.000622	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000124	0.000621	CcSEcCtD
Ketoprofen—Hyperhidrosis—Epirubicin—testicular cancer	0.000123	0.000617	CcSEcCtD
Ketoprofen—Insomnia—Methotrexate—testicular cancer	0.000123	0.000616	CcSEcCtD
Ketoprofen—Myalgia—Doxorubicin—testicular cancer	0.000122	0.000616	CcSEcCtD
Ketoprofen—Anxiety—Doxorubicin—testicular cancer	0.000122	0.000613	CcSEcCtD
Ketoprofen—Paraesthesia—Methotrexate—testicular cancer	0.000122	0.000612	CcSEcCtD
Ketoprofen—SLCO1A2—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.000122	0.00288	CbGpPWpGaD
Ketoprofen—Discomfort—Doxorubicin—testicular cancer	0.000121	0.000608	CcSEcCtD
Ketoprofen—Anorexia—Epirubicin—testicular cancer	0.000121	0.000608	CcSEcCtD
Ketoprofen—Dyspnoea—Methotrexate—testicular cancer	0.000121	0.000608	CcSEcCtD
Ketoprofen—Somnolence—Methotrexate—testicular cancer	0.000121	0.000606	CcSEcCtD
Ketoprofen—Dry mouth—Doxorubicin—testicular cancer	0.00012	0.000602	CcSEcCtD
Ketoprofen—Dyspepsia—Methotrexate—testicular cancer	0.000119	0.0006	CcSEcCtD
Ketoprofen—Confusional state—Doxorubicin—testicular cancer	0.000118	0.000595	CcSEcCtD
Ketoprofen—Decreased appetite—Methotrexate—testicular cancer	0.000118	0.000592	CcSEcCtD
Ketoprofen—Oedema—Doxorubicin—testicular cancer	0.000117	0.00059	CcSEcCtD
Ketoprofen—Anaphylactic shock—Doxorubicin—testicular cancer	0.000117	0.00059	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000117	0.000588	CcSEcCtD
Ketoprofen—Fatigue—Methotrexate—testicular cancer	0.000117	0.000588	CcSEcCtD
Ketoprofen—Infection—Doxorubicin—testicular cancer	0.000117	0.000586	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000116	0.000581	CcSEcCtD
Ketoprofen—Shock—Doxorubicin—testicular cancer	0.000115	0.000581	CcSEcCtD
Ketoprofen—Thrombocytopenia—Doxorubicin—testicular cancer	0.000115	0.000578	CcSEcCtD
Ketoprofen—Insomnia—Epirubicin—testicular cancer	0.000115	0.000577	CcSEcCtD
Ketoprofen—Tachycardia—Doxorubicin—testicular cancer	0.000115	0.000576	CcSEcCtD
Ketoprofen—Paraesthesia—Epirubicin—testicular cancer	0.000114	0.000573	CcSEcCtD
Ketoprofen—Hyperhidrosis—Doxorubicin—testicular cancer	0.000113	0.00057	CcSEcCtD
Ketoprofen—Dyspnoea—Epirubicin—testicular cancer	0.000113	0.000569	CcSEcCtD
Ketoprofen—Somnolence—Epirubicin—testicular cancer	0.000113	0.000567	CcSEcCtD
Ketoprofen—Anorexia—Doxorubicin—testicular cancer	0.000112	0.000562	CcSEcCtD
Ketoprofen—Feeling abnormal—Methotrexate—testicular cancer	0.000112	0.000562	CcSEcCtD
Ketoprofen—Dyspepsia—Epirubicin—testicular cancer	0.000112	0.000561	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Methotrexate—testicular cancer	0.000111	0.000557	CcSEcCtD
Ketoprofen—Decreased appetite—Epirubicin—testicular cancer	0.00011	0.000554	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Epirubicin—testicular cancer	0.00011	0.000551	CcSEcCtD
Ketoprofen—Fatigue—Epirubicin—testicular cancer	0.000109	0.00055	CcSEcCtD
Ketoprofen—Constipation—Epirubicin—testicular cancer	0.000108	0.000545	CcSEcCtD
Ketoprofen—Urticaria—Methotrexate—testicular cancer	0.000108	0.000541	CcSEcCtD
Ketoprofen—Abdominal pain—Methotrexate—testicular cancer	0.000107	0.000539	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000107	0.000538	CcSEcCtD
Ketoprofen—Insomnia—Doxorubicin—testicular cancer	0.000106	0.000534	CcSEcCtD
Ketoprofen—Paraesthesia—Doxorubicin—testicular cancer	0.000105	0.00053	CcSEcCtD
Ketoprofen—Dyspnoea—Doxorubicin—testicular cancer	0.000105	0.000526	CcSEcCtD
Ketoprofen—Feeling abnormal—Epirubicin—testicular cancer	0.000105	0.000526	CcSEcCtD
Ketoprofen—Somnolence—Doxorubicin—testicular cancer	0.000104	0.000525	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Epirubicin—testicular cancer	0.000104	0.000522	CcSEcCtD
Ketoprofen—Dyspepsia—Doxorubicin—testicular cancer	0.000103	0.000519	CcSEcCtD
Ketoprofen—Decreased appetite—Doxorubicin—testicular cancer	0.000102	0.000513	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000101	0.000509	CcSEcCtD
Ketoprofen—Fatigue—Doxorubicin—testicular cancer	0.000101	0.000509	CcSEcCtD
Ketoprofen—CXCR1—Signaling Pathways—H2AFZ—testicular cancer	0.000101	0.00239	CbGpPWpGaD
Ketoprofen—Urticaria—Epirubicin—testicular cancer	0.000101	0.000507	CcSEcCtD
Ketoprofen—CXCR1—Signaling Pathways—STK11—testicular cancer	0.000101	0.00238	CbGpPWpGaD
Ketoprofen—Constipation—Doxorubicin—testicular cancer	0.0001	0.000505	CcSEcCtD
Ketoprofen—Abdominal pain—Epirubicin—testicular cancer	0.0001	0.000504	CcSEcCtD
Ketoprofen—Hypersensitivity—Methotrexate—testicular cancer	9.99e-05	0.000502	CcSEcCtD
Ketoprofen—Asthenia—Methotrexate—testicular cancer	9.73e-05	0.000489	CcSEcCtD
Ketoprofen—Feeling abnormal—Doxorubicin—testicular cancer	9.67e-05	0.000486	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Doxorubicin—testicular cancer	9.6e-05	0.000483	CcSEcCtD
Ketoprofen—Pruritus—Methotrexate—testicular cancer	9.59e-05	0.000482	CcSEcCtD
Ketoprofen—Hypersensitivity—Epirubicin—testicular cancer	9.35e-05	0.00047	CcSEcCtD
Ketoprofen—Urticaria—Doxorubicin—testicular cancer	9.33e-05	0.000469	CcSEcCtD
Ketoprofen—CXCR1—Signaling Pathways—KITLG—testicular cancer	9.31e-05	0.0022	CbGpPWpGaD
Ketoprofen—Abdominal pain—Doxorubicin—testicular cancer	9.28e-05	0.000466	CcSEcCtD
Ketoprofen—Diarrhoea—Methotrexate—testicular cancer	9.28e-05	0.000466	CcSEcCtD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	9.26e-05	0.00219	CbGpPWpGaD
Ketoprofen—Asthenia—Epirubicin—testicular cancer	9.1e-05	0.000458	CcSEcCtD
Ketoprofen—Pruritus—Epirubicin—testicular cancer	8.98e-05	0.000451	CcSEcCtD
Ketoprofen—Dizziness—Methotrexate—testicular cancer	8.96e-05	0.000451	CcSEcCtD
Ketoprofen—Diarrhoea—Epirubicin—testicular cancer	8.68e-05	0.000436	CcSEcCtD
Ketoprofen—Hypersensitivity—Doxorubicin—testicular cancer	8.65e-05	0.000435	CcSEcCtD
Ketoprofen—Vomiting—Methotrexate—testicular cancer	8.62e-05	0.000433	CcSEcCtD
Ketoprofen—Rash—Methotrexate—testicular cancer	8.55e-05	0.00043	CcSEcCtD
Ketoprofen—Dermatitis—Methotrexate—testicular cancer	8.54e-05	0.000429	CcSEcCtD
Ketoprofen—Headache—Methotrexate—testicular cancer	8.49e-05	0.000427	CcSEcCtD
Ketoprofen—Asthenia—Doxorubicin—testicular cancer	8.42e-05	0.000423	CcSEcCtD
Ketoprofen—Dizziness—Epirubicin—testicular cancer	8.39e-05	0.000422	CcSEcCtD
Ketoprofen—Pruritus—Doxorubicin—testicular cancer	8.31e-05	0.000417	CcSEcCtD
Ketoprofen—Vomiting—Epirubicin—testicular cancer	8.07e-05	0.000405	CcSEcCtD
Ketoprofen—Nausea—Methotrexate—testicular cancer	8.05e-05	0.000405	CcSEcCtD
Ketoprofen—Diarrhoea—Doxorubicin—testicular cancer	8.03e-05	0.000404	CcSEcCtD
Ketoprofen—Rash—Epirubicin—testicular cancer	8e-05	0.000402	CcSEcCtD
Ketoprofen—Dermatitis—Epirubicin—testicular cancer	7.99e-05	0.000402	CcSEcCtD
Ketoprofen—Headache—Epirubicin—testicular cancer	7.95e-05	0.0004	CcSEcCtD
Ketoprofen—Dizziness—Doxorubicin—testicular cancer	7.76e-05	0.00039	CcSEcCtD
Ketoprofen—Nausea—Epirubicin—testicular cancer	7.54e-05	0.000379	CcSEcCtD
Ketoprofen—Vomiting—Doxorubicin—testicular cancer	7.46e-05	0.000375	CcSEcCtD
Ketoprofen—Rash—Doxorubicin—testicular cancer	7.4e-05	0.000372	CcSEcCtD
Ketoprofen—Dermatitis—Doxorubicin—testicular cancer	7.39e-05	0.000372	CcSEcCtD
Ketoprofen—Headache—Doxorubicin—testicular cancer	7.35e-05	0.00037	CcSEcCtD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	7.35e-05	0.00174	CbGpPWpGaD
Ketoprofen—Nausea—Doxorubicin—testicular cancer	6.97e-05	0.000351	CcSEcCtD
Ketoprofen—CXCR1—Signaling Pathways—FGFR3—testicular cancer	6.92e-05	0.00164	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—KIT—testicular cancer	6.35e-05	0.0015	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	5.98e-05	0.00142	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	5.95e-05	0.00141	CbGpPWpGaD
Ketoprofen—CXCL8—Metabolism of proteins—MMP2—testicular cancer	5.89e-05	0.00139	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—HPGDS—testicular cancer	5.42e-05	0.00128	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	4.87e-05	0.00115	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—H2AFZ—testicular cancer	4.57e-05	0.00108	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—STK11—testicular cancer	4.54e-05	0.00107	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—KITLG—testicular cancer	4.2e-05	0.000994	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—HPGDS—testicular cancer	4.12e-05	0.000976	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—STK11—testicular cancer	3.94e-05	0.000932	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—HPGDS—testicular cancer	3.27e-05	0.000775	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—FGFR3—testicular cancer	3.12e-05	0.000739	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—STK11—testicular cancer	3e-05	0.000709	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—KIT—testicular cancer	2.87e-05	0.000678	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—H2AFZ—testicular cancer	2.86e-05	0.000676	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—HPGDS—testicular cancer	2.66e-05	0.00063	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—HPGDS—testicular cancer	2.65e-05	0.000627	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—KITLG—testicular cancer	2.63e-05	0.000622	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—STK11—testicular cancer	2.38e-05	0.000563	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—HPGDS—testicular cancer	2.17e-05	0.000513	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—FGFR3—testicular cancer	1.95e-05	0.000462	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—STK11—testicular cancer	1.94e-05	0.000458	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—STK11—testicular cancer	1.92e-05	0.000455	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—KIT—testicular cancer	1.79e-05	0.000424	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—STK11—testicular cancer	1.58e-05	0.000373	CbGpPWpGaD
